GlaxoSmithKline Pharmaceuticals on Monday said it has made a foray into the oncology segment, bringing precision therapies ...

GlaxoSmithKline Pharmaceuticals has launched Jemperli and Zejula in India, pioneering precision therapies for gynaecological ...

GlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological ...

GSK enters oncology with Jemperli & Zejula for gynaecological cancers in India. Advanced therapies address unmet needs in ...

Jemperli is the first and only approved programmed death receptor-1 (PD-1) immunotherapy for the second-line treatment of ...

GlaxoSmithKline (GSK) has entered India's oncology sector with the launch of Jemperli and Zejula. These therapies address the increasing need for specialized cancer treatments.

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The DESTINY-Endometrial01 study aims to evaluate the ...

Here is our list of the 11 best cancer stocks to buy right now.

The cause of death of the beloved 'WKRP in Cincinnati' actress, who died on Aug. 3, has finally been confirmed.

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...